
Much has been written about prominent doctors who fail to disclose their lucrative financial ties with pharmaceutical and medical device companies.
(Jun 9, 2009)As Congress steps up its efforts to craft a comprehensive health care reform bill, Senator Edward Kennedy (in absentia) is leading the charge for a public health insurance option that can compete with
(Jun 16, 2009)Just yesterday, Senators Charles Grassley and Herbert Kohl announced that language requiring the public disclosure of payments to doctors from drug and medical device companies has been included in
(Jul 9, 2009)A week or so ago, I gave a talk to about 120 senior citizens at Brandeis University's Lifelong Learning Institute.
(Oct 6, 2009)The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs